Ian Hudson

Dr Hudson has extensive knowledge of the healthcare and pharmaceutical sector, having served as Chief Executive of the UK’s Medicines and Healthcare Products Regulatory Agency (“MHRA”) between 2013 and 2019.

Prior to this, he was the MHRA’s Licensing Director, responsible for most of the agency’s medicines licensing activities.

Before joining the MHRA, Dr Hudson held various senior roles at SmithKline Beecham, working for more than a decade in clinical research and development. Dr Hudson is currently serving as Senior Advisor, Integrated Development for the Bill and Melinda Gates Foundation, working in areas that include optimising clinical studies and strengthening regulatory systems in low-resource regions, as well as providing regulatory input to teams working on malaria, polio, and COVID-19 drugs.

In 2020, he was awarded an OBE for Services to Healthcare, received a Faculty of Pharmaceutical Medicine President’s medal for contribution to pharmaceutical medicine, and was named a Global Fellow in Medicines Development by the International Federation of Associations of Pharmaceutical Physicians and Pharmaceutical Medicine.